According to a research article titled "Transforming the Medical Device Industry: Road Map to a Circular Economy" published in December 2020, the healthcare system of high-income countries is mostly based on a linear supply chain that includes single-use disposable medical devices. This raises healthcare costs while also causing waste and pollution, all of which have a negative impact on the surrounding ecosystem. As a result, recycling medical devices minimizes the amount of medical waste produced while also propelling market growth. Furthermore, growing demand for recycling and reusability due to reasons such as increased public awareness and campaigns by various non-governmental organizations (NGO) acting in favor of reducing medical waste and improving recycling measures.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-single-use-medical-devices-reprocessing-market
Data Bridge Market Research analyses that the Single Use Medical Devices Reprocessing Market, which was USD 2,378.97 million in 2020, is expected to reach USD 8,017.03 million by 2028, at a CAGR of 16.40% during the forecast period of 2021-2028. Cost savings from reprocessing single-use medical equipment, rising regulatory pressure to limit the volume of medical waste, the rising burden of chronic diseases, and the growing elderly population are likely to drive the market examined. Furthermore, the industry is likely to benefit from the launch of new operations and the implementation of important initiatives such as mergers and acquisitions.
Growing prevalence of chronic diseases is expected to drive the market's growth rate
The global population is aging, and the number of people over the age of 65 is expected to increase significantly in the coming years. This is leading to an increased demand for healthcare services, including medical procedures that require single-use medical devices. The rising prevalence of chronic diseases, such as heart disease, cancer, and diabetes, is leading to an increased demand for medical procedures. This is driving the demand for single-use medical devices, which can be reprocessed and reused.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2021 to 2028
|
|
Base Year
|
2020
|
|
Historic Years
|
2019 (Customizable to 2013- 2018)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Class I Devices and Class II Devices), Price Range (High Range and Low/Economy Range), Application (General Surgery, Anesthesia, Arthroscopy and Orthopaedic Surgery, Cardiology, Gastroenterology, Urology, Gynaecology and Others), Type (In-House and Outsource), End User (Hospitals, Ambulatory Surgical Centers, Others), Distribution Channel (B2B and B2C)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Johnson & Johnson Services, Inc. (U.S.), Stryker (U.S.), SureTek Medical (U.S.), Medline Industries, Inc. (U.S.), Vanguard AG (U.S.), NEScientific, Inc. (U.S.), SteriPro (Canada), INNOVATIVE HEALTH (U.S.), and ReNu Medical (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
Global single use medical devices reprocessing market is categorized into six notable segments which are based on product type, price range, application, type, end user and distribution channel.
- On the basis of product type, global single use medical reprocessing market is segmented into class I devices and class II devices. Class II devices segment is expected to dominate the global single use medical reprocessing market and is expected to reach USD 8,200.84 million by 2030 due to high technology adoption by key players in the market.
- On the basis of price range, global single use medical reprocessing market is segmented into high range and low/economy range. High range segment is expected to dominate the global single use medical reprocessing market and is expected to reach USD 7,634.85 million by 2030 because players in the market reprocess several devices in this category.
- On the basis of application, global single use medical reprocessing market is segmented into general surgery, anesthesia, arthroscopy and orthopedic surgery, cardiology, gastroenterology, urology gynecology and others. Cardiology segment is expected to dominate the global single use medical reprocessing market and is expected to reach USD 3,508.46 million by 2030 due to large number of devices are getting reprocessed under cardiology.
- On the basis of type, global single use medical reprocessing market is segmented into market is segmented into in-house and outsource. In-house segment is expected to dominate the global single use medical reprocessing market and is expected to reach USD 8,455.07 million by 2030 because most hospitals are reprocessing the devices in-house.
- On the basis of end user, global single use medical reprocessing market is segmented into hospitals, ambulatory surgical centers and others. Hospitals segment is expected to dominate the global single use medical reprocessing market and is expected to reach USD 7284.16 million by 2030 because ultimately these devices are used in hospitals to treat the patients.
The hospitals segment will dominate the end user segment of the single use medical devices reprocessing market
The hospitals segment will emerge as the dominating segment end user segment. This is because of the growing number of hospitals in the market especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
- On the basis of distribution channel, global single use medical reprocessing market is segmented into B2B and B2C. B2B segment is expected to dominate the global single use medical reprocessing market and is expected to reach USD 8,874.27 million by 2030 because consumers are aware of this distribution channel and they prefer B2B for seeking the benefits of discounts, bulk buying and easy availability of products.
The B2B segment will dominate the distribution channel segment of the single use medical devices reprocessing market
The B2B segment will emerge as the dominating segment under distribution channel. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.
Major Players
Data Bridge Market Research recognizes the following companies as the major market players: Johnson & Johnson Services, Inc. (U.S.), Stryker (U.S.), SureTek Medical (U.S.), Medline Industries, Inc. (U.S.), Vanguard AG (U.S.), NEScientific, Inc. (U.S.), SteriPro (Canada), INNOVATIVE HEALTH (U.S.), and ReNu Medical (U.S.).
Market Development
- In 2022, Innovative Health LLC was granted permission to reprocess Boston Scientific's INTELLAMAP ORION High-resolution Mapping Catheter in January. The catheter is commonly used in atrial fibrillation catheter ablation operations.
- In 2020, Stryker launched the Reprocessed MyoSure Tissue Removal Device for Single Use in October, which is used to hysteroscopically remove intrauterine tissue. The Stryker Reprocessed MyoSure Tissue Removal Device is a valuable option for women who need to have intrauterine tissue removed. It is a minimally invasive procedure that can be performed in an outpatient setting. The device is also a cost-effective option, as it can be reprocessed and reused.
Regional Analysis
Geographically, the countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the single use medical devices reprocessing market during the forecast period 2021-2028
North America is predicted to dominate the market due to increased investments in the development of novel testing methods. Given the surge in epidemic and pandemic occurrences, as well as the availability of modern healthcare infrastructure, the United States dominates the North American market.
Asia-Pacific is estimated to be the fastest growing region in the single use medical devices reprocessing market in the forecast period 2021-2028
Asia-Pacific is expected to grow at the fastest rate due to rising investments and the entry of major companies such as Stryker, Scientific Inc., and ReNu Medical, which are investing in developing testing methods that favor results with high accuracy and short turnaround time. With strong government support and increased financing for the development of recycled devices, China dominates the Asia-Pacific market.
For more detailed information about the single use medical devices reprocessing market report, click here – https://www.databridgemarketresearch.com/reports/global-single-use-medical-devices-reprocessing-market
